Award
NIH Reporter #1P50CA310825-01
Developing Novel Combination Immunotherapeutics for Non–Muscle-Invasive Bladder Cancer
Recipient
Sloan Kettering Institute for Cancer Research
Award Amount
$514,639.00
Ceiling
$514,639.00
Awarded
September 17, 2026
Identifier
1P50CA310825-01
The project will study how dendritic cells shape antitumor immune responses in non–muscle-invasive bladder cancer and assess 2141-V11, alone and in combinations with BCG and IL-15/IL-15Rα, in preclinical models and clinical studies.
Description
Research project investigating dendritic-cell responses to CD40 agonism, BCG, and other immunotherapies, and testing combination immunotherapeutic strategies for non–muscle-invasive bladder cancer.